Hanna Kim completed her B.S. in Biology from Caltech, Pasadena, CA. She obtained an M.D. from the University of California, Irvine, and completed a pediatrics residency at Children’s National Medical Center in Washington, D.C. Dr. Kim’s pediatric rheumatology fellowship was at A.I. Dupont Children’s in Wilmington, DE, Children’s National, and NIAMS/NIH in Bethesda, MD. She completed advanced postdoctoral training as a Lawrence Shulman scholar in the NIAMS Pediatric Translational Research Branch. Currently, as a board-certified pediatric rheumatologist and assistant clinical investigator, she is the head of the Juvenile Myositis Pathogenesis and Therapeutics Unit at NIAMS / NIH.
Dr. Kim’s research is focused on juvenile myositis, including clinical and translational research on novel biomarkers and their association with disease activity and pathogenesis. In addition to detailed research evaluations of juvenile myositis patients at NIH, she also leads clinical trials of novel treatments in clinical trials in juvenile myositis, including leading a prior study on baricitinib (janus kinase inhibitor).
She is also an Associate Clinical Professor of Medicine at George Washington University, where she sees patients and collaborates on research on juvenile myositis in the Myositis Clinic Cure JM Center of Excellence. She is actively involved in a range of organizations, including the American College of Rheumatology (ACR), the Childhood Arthritis Rheumatology Research Alliance (CARRA), and the International Myositis Assessment and Clinical Studies Group.
Dr. Kim has received numerous local, national, and international awards and honors, including NIAMS Group Merit Award, ACR Distinguished Fellow Award, Rheumatology Research Foundation Pediatric Research Award, Pediatric Rheumatology European Society Young Investigator Travel Award, selection for the ACR-European League Against Rheumatism Early Investigator Exchange Program, best abstract at the Global Conference on Myositis, and the CARRA Early Investigator Award.